The groundbreaking treatment of the medication represents a exciting advance in the management of type 2 diabetes. Different to existing drugs, tirzepatide affects two pathways – GLP-1 and GIP – providing enhanced https://tirzepatidepeptide311080.csublogs.com/49958169/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment